| Application no. and date | 00947994.0 (espacenet) (Federated) (European Patent Register), 20000725 | | Patent/reg. no. and date | DK/EP 1206281, 20040630 | | Publication date | 20020522 | | Priority no. and date | DE 19937116, 19990806 | | EP pub. no. and date |
EP 1206281 20020522 | | Effective date | | | Applicant/owner | Bayer Intellectual Property GmbH, Alfred-Nobel-Straße 10
40789 Monheim, DE | | Applicant ref. no. | 117302 | | Inventor | KÜHN, Bernd, Hahnenweg 2
D-51061 Köln, DE,
MAHLER, Hans-Friedrich, Haferkamp 6
D-51061 Köln, DE,
EISELE, Michael, An der Flora 2 a
D-51469 Bergisch Gladbach, DE | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | A61K 31/47, A61K 47/02, A61K 31/4709 | | Title | Formulering indeholdende moxifloxacin og natriumchlorid | | Int. application no. | EP2000007098 | | Int. publication no. | WO2001010465 | | Related patent (certificate) | | | Status | Udløbet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
